About Advanced Oxygen Therapy
Advanced Oxygen Therapy is a company based in Oceanside (United States) founded in 2004. Advanced Oxygen Therapy offers products and services including TWO2 Extremity Chamber, TWO2 Multi-Patch, and NEXA NPWT System. Advanced Oxygen Therapy operates in a competitive market with competitors including Natrox, EO2Concepts, Vaporox, InotecAMD and Teknomar, among others.
- Headquarter Oceanside, United States
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aotinc.net
- Social LinkedIn X Facebook YouTube
- Legal Name Aoti, Inc.
- Annual Revenue$67.99 M (USD)10.55as on Dec 31, 2025
- Net Profit$2.72 M (USD)0as on Dec 31, 2025
- EBITDA$7.85 M (USD)149.72as on Dec 31, 2025
- Latest Funding Round$12M (USD), Debt – Conventional
Mar 2022
- Investors
Products & Services of Advanced Oxygen Therapy
Advanced Oxygen Therapy offers a comprehensive portfolio of products and services, including TWO2 Extremity Chamber, TWO2 Multi-Patch, and NEXA NPWT System.
Delivers topical oxygen to extremities for wound healing.
Provides oxygen and compression for various wound types.
Supports wound management with advanced innovations.
Apps and channels of Advanced Oxygen Therapy
its YouTube channel AOTI has 470 subscribers and 23 videos.
Videos from Advanced Oxygen Therapy
The most watched videos on Advanced Oxygen Therapy's YouTube channel, AOTI (470 subscribers). Click a video to play it here.
More on AOTI.
Funding Insights of Advanced Oxygen Therapy
- Total Rounds 1
- Last Round Debt – Conventional — $12M
- First Round $12M
(Mar 2022)
- Investors Count 1
All 1 funding rounds of Advanced Oxygen Therapy with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $12M | Debt – Conventional | – | – |
1 investors in total: 1 institutional.
Investors in Advanced Oxygen Therapy
Advanced Oxygen Therapy has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SWK Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments and advisory services are provided by the holding company. | 2009 | swkhold.com | Dallas, United States |
Investor details for Advanced Oxygen Therapy
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Advanced Oxygen Therapy
25 people are tracked at Advanced Oxygen Therapy (18 in leadership, 1 in board & advisors, 6 in team).
| Name | Role | Group |
|---|---|---|
Marty Sylvain | Chief Advocacy Officer | Leadership |
Matthew Garoufalis | Chief Medical Officer | Leadership |
Gerry Coughlan | VP of R&D, Operations & Manufacturing | Leadership |
Stacy Reel | Chief Commercial Officer (cco) | Leadership |
Anthony Moffatt | Chief Operating Officer | Leadership |
Gina So'Oto | Director Of Human Resources | Leadership |
Stacey H. | Director Of Operations, Medicaid | Leadership |
Mike Griffiths | CEO & President | Leadership |
Robbie Walsh | VP Quality Assurance & Regulatory Affairs | Leadership |
Despi Herodotou | Vice President Of Research And Clinical Innovation | Leadership |
Keith Heaton | Chief Innovation Officer | Leadership |
Evelyn Quintin | Associate Director, Clinical Operations | Leadership |
David Bennett | VP, Compliance & Technical Services | Leadership |
David Hammond | President, International | Leadership |
Freddy Schwab | VP Sales And Marketing | Leadership |
Melodie Blakely | Senior Director Of Market Access, Value And RWE | Leadership |
Moustafa El-Gohary | Director Of Marketing & Sales: Middle East, Africa, Central Asia, Turkey & Indian Subcontinent | Leadership |
Darron Daly Ms | Executive Vice President Of Marketing And Professional Relations | Leadership |
Doug Le Fort | Senior Strategic Advisor | Board & advisors |
Sarah Gould | Senior Manager, Talent Acquisition | Team |
5 more people are available in the full profile.
Complete people profiles for Advanced Oxygen Therapy
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Advanced Oxygen Therapy
Advanced Oxygen Therapy is a publicly listed company on the LSE with ticker symbol AOTI in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Jun 2024
- Listed onLSE: AOTI
- Listed entityAOTI, Inc.
- Exchange sectorHealth technology
- ISINUS03690C1027
- Share price132.50 GBX · 2026-10-09
- Market capitalisation140,925,894.00 GBX
Financials of Advanced Oxygen Therapy
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 50.5M GBP | 2.0M GBP | 5.8M GBP |
| 2024 | 45.7M GBP | -1.4M GBP | 2.3M GBP |
| 2023 | 35.3M GBP | -6.6M GBP | -3.3M GBP |
| 2022 | 8.9M GBP | 1.7M GBP | 2.8M GBP |
| 2021 | 889,270 GBP | -86,840 GBP | 12,230 GBP |
Detailed financial statements for Advanced Oxygen Therapy
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Advanced Oxygen Therapy
3 dated milestones of Advanced Oxygen Therapy across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Advanced Oxygen Therapy is founded.
- Funding First funding round of $12.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Advanced Oxygen Therapy
Advanced Oxygen Therapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natrox, EO2Concepts, Vaporox, InotecAMD and Teknomar, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| natroxwoundcare.com | 2003 | Waterbeach, United Kingdom | $68.39M | 31 | Oxygen-based wound therapy devices are developed for healing non-healing wounds. | |
| eo2.com | 2007 | San Antonio, United States | $31.11M | 19 | Continuous oxygen diffusion devices for chronic wound care are developed. | |
| vaporox.com | 2016 | Denver, United States | $2.25M | – | Developer of medical device for the wound treatment | |
| inotecamd.com | 2003 | Cambridge, United Kingdom | – | 14 | Chronic wound solutions are developed via portable oxygen-enrichment devices. | |
| teknomar.eu | 1993 | Ankara, Turkey | – | – | Produces sterilization devices, air sterilizers, and wound care equipment for medical use. | |
| numobag.com | 2006 | Northridge, United States | $950,000 | – | Topical hyperbaric oxygen therapy for wound healing is developed. | |
| oz-recovery.com | 1995 | Ramat Gan, Israel | – | – | Provides a medical device designed for chronic wound healing. |
Detailed competitors of Advanced Oxygen Therapy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Advanced Oxygen Therapy
The website of Advanced Oxygen Therapy (aotinc.net) receives about 3.9K visits a month.
- Monthly visits3.9K
▲ 9.9% vs previous month
Latest news on Advanced Oxygen Therapy
Complete news archive for Advanced Oxygen Therapy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Advanced Oxygen Therapy
10 companies that operate in the same segment as Advanced Oxygen Therapy (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Advanced Oxygen Therapy
Advanced Oxygen Therapy was founded in 2004 and raised its 1st funding round 18 years after it was founded.
Advanced Oxygen Therapy is headquartered in Oceanside, United States. It is registered at Oceanside, California, United States.
Annual revenue of Advanced Oxygen Therapy is $67.99M as on Dec 31, 2025.
Advanced Oxygen Therapy was founded in 2004 and is located in Oceanside, United States. Solutions for treating severe acute and chronic wounds are developed within the medical device sector. Operations focus on products such as single-use Topical Wound Oxygen extremity chambers, single-use Topical Wound Oxygen Sacral systems for torso wounds including pressure ulcers, and reusable extremity chambers. The companys domain is aotinc.net.
Advanced Oxygen Therapy's top competitors include Natrox, Vaporox and EO2Concepts.
Advanced Oxygen Therapy offers TWO2 Extremity Chamber, TWO2 Multi-Patch, and NEXA NPWT System.
Yes, Advanced Oxygen Therapy is publicly traded on LSE under the ticker symbol AOTI.
Advanced Oxygen Therapy has 1 investor. Key investors include SWK Holdings.
Advanced Oxygen Therapy operates through Advanced Oxygen Therapy Inc..